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Signs	&	Symptoms	
Clostridium	Difficile	Infec8on		
Adamu,	BSN,	RN	
Introduc8on		
• Clostridium	difficile	infec8on	
(CDI)	refers	to	bacterium	that	
infects	the	gut	thereby	causing	
diarrhea	
• It	is	a	spore-forming	bacterium	
that	lives	in	the	colon.	It	
provides	an	environment	that	is	
favorable	for	mul8plica8on	of	
spores	(Deshpande, Pant, 
Olyaee, & Donskey,  2018).	
• The	use	of	an8bio8cs	can	
promote	growth	of	Clostridium	
difficile	
• Clostridium	difficile	produce	
toxins	A	and	B	which	causes	
diarrhea	and	inflamma8on.	
• Diarrhea	is	the	most	common	
symptom	for	Clostridium	
difficile	
• Treatment	involves	stopping	
use	of	an8bio8cs	
• Clostridium	difficile	infec8on	
tends	to	recur	in	the	course	of		
an8bio8c	treatment	(Luo & 
Barlam,  2018).	
• There	are	several	treatment	
op8ons	for	trea8ng	recurring	
Clostridium	difficile	infec8on	
• Surgery	is	necessary	when	
Clostridium	difficile	infec8ons	
do	not	respond	to	other	
treatment	regimens.	
									The	Topic	of	Choice	 References	Reasons	for	Choosing	
the	Topic		
•  The	topic	of	choice	for	this	
presenta8on	is	Clostridium	
difficile	infec8on		
•  The	topic	focuses	on	
prevalence	of	this	infec8on	in	
the	United	States	
•  The	pathogen	is	ubiquitous	in	
nature	
•  The	bacteria	is	commonly	
found	in	the	soil	(Deshpande	et	
al.,2018).	
•  The	bacterium	appears	as	
irregular	cells	when	observed	
under	a	microscope	
•  The	bacteria	is	tolerable	to	
extreme	condi8ons	
•  Produces	mul8ple	toxins	
•  There	are	mul8ple	risk	
factors	for	Clostridium	difficile	
infec8on			
•  Common	risk	factors	include	
an8bio8cs,	acid	suppression	
medica8on,	and	elemental	diet.	
•  There	is	a	lot	that	needs	to	be	
known	about	Clostridium	difficile	
infec8on	especially	early	recogni8on	
and	preven8on	of	infec8on	
•  The	infec8on	impacts	nega8vely	
on	quality	of	healthcare	delivery	
•  This	infec8on	has	prompted	
search	for	alterna8ve	treatment	
op8ons	besides	an8bio8cs		
•  	Pa8ents	needs		has	become	
increasingly	difficult	hence	the	need	
for	pa8ent	and	family	educa8on.	
•  Nurses		have	a	role	in	treatment		
and	preven8on	of	Clostridium	
difficile	infec8on		through	enhanced	
contact	precau8ons	and		me8culous	
hand	hygiene	(Desai,	et	al.,	2016).	
	
Significance	of	
Pathophysiolo		
•  Helps	in	early	iden8fica8on	
of	signs	and	symptoms	
•  Allows	physicians	to	choose	
appropriate	treatment	
•  Is	helpful	when	choosing	
preven8ve	measures		
•  Reduces	the	risk	of	
recurrence		(Luo	&	Barlam,		
2018)	
•  Helps	in	immediate	isola8on	
of	infected	individuals	
Conclusion	
•  Clostridium	difficile	infec8on	is	
a	major	healthcare	concern	yet-
under-appreciated	
•  Causes	significant	morbidity	
and	mortality	
•  Prevalence	of	this	problem	in	
the	US	has	been	increasing	
steadily	in	recent	years	
•  There	are	mul8ple	risk	factors	
for	Clostridium	difficile	infec8on	
•  The	most	prominent	risk	factor	
is	an8bio8c	treatment	
•  The	problem	can	be	prevented	
by	using	alterna8ve	treatment	
op8ons	and	adhering	to	
me8culous	hand	hygiene.	
	
	
		
	
	
• Clostridium	difficile	is	a	serious	
emerging	healthcare	issue	
• It	is	a	public	health	problem	
• Nearly	500,000	infec8ons	and	
29,000	deaths	that	occur	
annually	in	the	U.S	are	
aYributable	to	Clostridium	
difficile	infec8on		
• This	infec8on	has	led	to	an	
increase	in	the	number	of	
pa8ents	who	need	admission	to	
ICU	(Luo	&	Barlam,		2018)		
	
•  Clostridium	difficile	infec8on	
is	an	enormous	healthcare	
issue	yet	underappreciated	
•  The	public	has	limited	
knowledge	on	this	issue	
•  There	is	dearth	of	informa8on	
in	regards	to	the	par8cular	
type	of	an8bio8cs	that	cause	
CDI	
•  Is	the	leading	cause	of	
nosocomial	infec8ous	
diarrhea	
•  This	problem	is	associated	
with	significant	financial	
burden	
•  The	economic	impact	of	CDI	is	
expected	to	increase	in	
coming	years	(Desai,	Gupta,	
Dubberke,	Prabhu,	Browne,	&	
Mast,	2016).	
Illustration	below	retrieved	From	www.cdc.gov	
				Implica8ons	for	
Nursing	Care	
•  Clostridium	difficile	
infec8ons	are	either	
endogenous	or	exogenous	
•  Endogenous	infec8on	is	
caused	by	carrier	strain	
•  Exogenous	infec8on	is	
acquired		from	contaminated	
healthcare	providers	(Ofosu,	A.	
2016).		
•  The	infec8ons	spreads	
through	the	fecal	oral	route	
•  The	infec8on	occurs	in	the	
large	intes8ne.	
•  Another	factor	may	be	host	
suscep8bility	and	bacteria	
virulence.	
•  The	mul8plica8on	of	the	
bacterium	causes	severe	
damage	to	intes8nal	crypts	
(Deshpande	et	al.,2018)	
Underlying	
Pathophysiology	
Illustra8ve	Figure	
•  The	pathophysiology	of	Clostridium	difficile	infec8on	occurs	in	
three	phases	
•  The	three	phases	include	microbial	suppression,	collateral	
damage,	and	a	window	of	vulnerability.	
•  The	microbial	suppression	phase	entails	the	suppression	of	
the	protec8ve	ability	of	intes8nal	microbiota		
•  The	suppression	of	intes8nal	microbiota	is	o^en8mes	caused	
by	using	an8bio8cs	for	treatments	
•  The	collateral	damage	phase	entails	the	disrup8on	of	the	
intes8nal	microbiota	
•  Bacterium	comes	close	to	epithelium	
•  The	last	phase	is	window	of	vulnerability	
•  This	phase	involves	recurrence	of	the	infec8on	in	the	course	
of	treatment	(Luo	&	Barlam,		2018).	
•  Even	though	everyone	is	at	risk	of	ge_ng	infected	with	
Clostridium	difficile,	the	degree	of	risk	markedly	varies.	
•  	long-term	use	of	proton	inhibitors	is	associated	with	
Clostridium	difficile	infec8on	leading	to	increased	morbidity	and	
mortality	rates	(McDonald,	E.G,	Milligan,	J.,	FreneYe,	C.,	Lee,T.	C.	
2015).	
•  Also	some	people	get	infected	whiles	others	do	not,	because		
these	individuals	who		get	infected	do	not	adhere	to	high	levels	
of	hygiene.	
•  Age	65	years	and	older	are	at	risk	
•  Current	or	recent	use	of	an8bio8c		(cdc.gov)	
Pathophysiological	Processes	
•  Watery	diarrhea	three	or	
more	8mes	a	day	las8ng	for	at	
least	two	days	
•  Mild	abdominal	cramping	and	
tenderness	
•  Blood	in	stool	
•  Rapid	heart	rate	
•  Kidney	failure	
•  Swollen	abdomen	
•  Increased	white	blood	cell	
count	
•  Loss	of	appe8te	
•  Dehydra8on	
•  Fever	
•  Weight	loss	(Lee,	&	Fishman,		
2017)	
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